Rights and permissions
About this article
Cite this article
Rituximab appears to be effective in the treatment of primary cutaneous B-cell lymphoma. Inpharma Wkly. 1265, 13 (2000). https://doi.org/10.2165/00128413-200012650-00028
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200012650-00028